EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation

Mohammad Yasin Zamanian iD, Lusine G Khachatryan, Mahzad Heidari, Razieh Darabi, Maryam Golmohammadi, Raed Fanoukh Aboqader Al-Aouadi, Esra Küpeli Akkol

BioFactors · 2025-09 · 51 (5)

DOI: 10.1002/biof.70047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 03.09.2025. Verfasst von Mohammad Yasin Zamanian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Flavonols, Neuroprotective Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 283 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by amyloid‐β (Aβ) aggregation, oxidative stress, and neuroinflammation, remains a significant global health challenge. This study investigates the therapeutic potential of flavonols—quercetin, kaempferol, myricetin, and fisetin—in targeting Aβ aggregation and mitigating AD pathology through diverse molecular mechanisms. Our findings reveal that flavonols effectively inhibit Aβ oligomerization and fibril formation, reduce oxidative stress via Nrf2/HO‐1 pathway activation, and suppress neuroinflammation by modulating microglial polarization. Additionally, these compounds enhance mitochondrial function, promote autophagy‐mediated clearance of Aβ aggregates, and regulate key enzymes such as β‐secretase (BACE1) and α‐secretases (ADAM10/17), favoring non‐amyloidogenic pathways. Quercetin demonstrated neuroprotective effects by activating TrkB signaling, reducing tau phosphorylation, and enhancing synaptic plasticity. Kaempferol prevented Aβ‐induced apoptosis via the ER/ERK/MAPK pathway and inhibited acetylcholinesterase activity, improving cognitive outcomes. Myricetin ameliorated mitochondrial dysfunction and oxidative damage through GSK3β/ERK2 signaling modulation and showed enhanced brain bioavailability when delivered via nanostructured lipid carriers. Fisetin reduced Aβ burden by upregulating neprilysin expression, suppressed neuroinflammation, and improved synaptic function by restoring synaptic protein levels. Overall, flavonols exhibit multi‐targeted therapeutic potential against AD by addressing its complex pathogenesis. Their ability to cross the blood–brain barrier and low toxicity profiles position them as promising candidates for further clinical development. This study underscores the potential of flavonols as natural agents for AD treatment and highlights their role in advancing multi‐mechanistic therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesFlavonolsNeuroprotective AgentsNeuroinflammatory DiseasesOxidative StressAnimalsKaempferolsFlavonoidsQuercetinMiceHumansMaleMitochondriaSignal TransductionAmyloid Precursor Protein Secretases

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid‐β aggregationflavonolsneuroprotectionoxidative stress

Substanzen

Amyloid beta-PeptidesFlavonolsfisetinkaempferolKaempferolsFlavonoidsNeuroprotective AgentsQuercetinmyricetinAmyloid Precursor Protein Secretases

Autor:innen und Institutionen

  • Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Children's Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Department of Neurology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Ophthalmology, David Geffen School of Medicine, Los Angeles, California, USA.
  • College of Medicine, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq.

ORCID-Profile: Mohammad Yasin Zamanian

Zitieren

APA

Zamanian, M. Y., Khachatryan, L. G., Heidari, M., Darabi, R., Golmohammadi, M., Al-Aouadi, R. F. A., & Akkol, E. K. (2025). The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation. BioFactors, 51(5). https://doi.org/10.1002/biof.70047

Vancouver

Zamanian MY, Khachatryan LG, Heidari M, Darabi R, Golmohammadi M, Al-Aouadi RFA, et al. The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation. BioFactors. 2025;51(5). doi:10.1002/biof.70047

BibTeX
@article{Zamanian2025,
  author = {Zamanian, Mohammad Yasin and Khachatryan, Lusine G and Heidari, Mahzad and Darabi, Razieh and Golmohammadi, Maryam and Al-Aouadi, Raed Fanoukh Aboqader and Akkol, Esra Küpeli},
  title = {The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation},
  journal = {BioFactors},
  year = {2025},
  volume = {51},
  number = {5},
  doi = {10.1002/biof.70047}
}
Kostenlos starten →